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Abstract
Introduction: The aim of this study was an investigation into the individual and socio-economic risk factors of the incidence of thyroid
carcinoma.
Material and methods: Our study was into risk factors affecting the incidence of thyroid carcinoma conducted in patients included in
a register of thyroid carcinoma. For that purpose, a questionnaire was prepared which covered personal information, medical history and
socio-economic factors. A statistical analysis was conducted.
Results: The register comprised 297 patients (89% female) with thyroid carcinoma and 589 healthy subjects. Age group distribution was
similar for both groups. The largest group was aged 50–54. The number of children born to women with carcinoma and women in the
control group did not differ significantly. 10% of the women with carcinoma had used contraception. Patients were most frequently born
in Olsztyn province, an area of relative iodine deficiency. 9.72% had suffered from thyroid disease in childhood. 32.41% had a family
history of thyroid disease. Mothers of patients most frequently also came from regions of similar iodine level. The fathers most frequently
came from Warsaw province (17.08%). The origin of the remainder was the same as of the mothers. 36% of patients had elementary, 14%
vocational, 38% secondary and 13% higher education. Logistic regression showed that the risk of carcinoma increased 0.98 times in each
person younger by a year. Individuals with body mass lower had 0.98 times greater risk of the disease by each kilogram.
Conclusions: The risk factors for the incidence of thyroid carcinoma: female sex, age at onset, low body mass
(Pol J Endocrinol 2010; 61 (5): 671–682)
Key words: thyroid carcinoma, individual and socio-economic risk factors
Streszczenie
Wstęp: Celem pracy było zbadanie osobniczych i socjoekonomicznych czynników ryzyka zapadalności na raka tarczycy.
Materiał i metody: Badanie przeprowadzono wśród chorych objętych rejestrem raka tarczycy na podstawie przygotowanej ankiety.
Ankieta zawierała: informacje osobnicze, historię medyczną oraz czynniki socjoekonomiczne. Uzyskane dane poddano analizie staty-
stycznej.
Wyniki: Rejestrem objęto 297 chorych (89% kobiet) i 589 zdrowych ochotników dobranych odpowiednio pod względem wieku i miejsca
zamieszkania. Najczęstszą grupę stanowili chorzy w wieku 50–54, z dominującą grupą kobiet. Kobiety chore na raka tarczycy rodziły tak
samo często, jak kobiety z grupy kontrolnej; 10% stosowało leki antykoncepcyjne. Większość chorych urodziło się w województwie
olsztyńskim (obszar umiarkowanego niedoboru jodu). U 9,72% w dzieciństwie rozpoznano chorobę tarczycy. Rodzinne obciążenie choro-
bami tarczycy miało 32,41%. Wykształceniem podstawowym legitymowało się 36%, 14% zawodowym, 38% średnim i 13% wyższym.
Na podstawie modelu regresji logistycznej wykazano, że ryzyko raka tarczycy wzrastało 0,98-krotnie u każdej osoby młodszej o rok
i 0,98-krotnie z masą ciała niższą o 1 kg.
Wnioski: Czynniki ryzyka zapadalności na raka tarczycy to: płeć żeńska, wiek rozpoznania raka tarczycy, niska masa ciała.
(Endokrynol Pol 2010; 61 (5): 671–682)
Słowa kluczowe: rak tarczycy, osobnicze i socjoekonomiczne czynniki ryzyka
Aktualne granty, inne źródła finansowania:
1. Wpływ modeli żywienia kobiet z przebytą cukrzycą ciążową na rozwój zespołu metabolicznego u kobiet oraz nadwagi i otyłości u potomstwa
— grant Ministerstwa Nauki i Szkolnictwa Wyższego, zakwalifikowany do finansowania w 38. konkursie
2. Program badań przesiewowych w kierunku retinopatii cukrzycowej w województwie warmińsko-mazurskim — projekt współfinansowany
przez firmy Novo Nordisk Pharma Sp. z o. o. i Roche Diagnostics Polska Sp. z o.o.
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Introduction
Thyroid carcinoma comprises as little as 1% of all neo-
plasms; however, they are the commonest form of en-
docrine gland cancer [1–5]. The growth of interest in
this group of carcinomas in the 1990s was the conse-
quence of advances in diagnostics, especially ultrasono-
graphic thyroid examination, which contributed to
a massive increase in random recognition of thyroid car-
cinoma (‘incidentaloma’). Another factor that caused
growth of interest in thyroid carcinoma was the Cher-
nobyl accident in 1986. One of the elements in the radio-
active downfall was radioactive iodine, which upon de-
positing in the thyroid gland brought about a consider-
able rise in the incidence of cancer. The evidence for this
includes the observations of thyroid carcinoma in chil-
dren made in Belarus four years after Chernobyl [6–8].
The aim of our study was to investigate individual
and socio-economic risk factors in the incidence of thy-
roid carcinoma.
Material and methods
A prospective study on thyroid cancer was conducted
in Olsztyn province from 1 January 1994 to 31 Decem-
ber 2003. Olsztyn province is in the north-east of Po-
land, with an area of 12,327 km2 (3.9% of Poland’s area).
In 1994, its population was 769,200 and in 2002 it was
760,737, making up 2% of the whole Polish population.
In 1994, 22 towns in the province were inhabited by
60% of the province’s population [10–12].
The register of thyroid carcinoma included patients
for the following criteria:
— disease onset between 1 January 1994 and 31 De-
cember 2003
— permanent residents of Olsztyn province, with re-
spect to all age groups
— thyroid carcinoma was diagnosed on post-operational
histopathological thyroid examination classified as
ICD-9, ICD-10 at the Department of Pathomorphol-
ogy of the District Specialistic Hospital in Olsztyn and
verified at the Department of Pathomorphology of
the Medical Academy in Warsaw or the Oncological
Centre of Institute in Gliwice [13, 14].
The study was into factors affecting the incidence
of thyroid carcinoma conducted among patients includ-
ed in the standardised register. For that purpose, a ques-
tionnaire was prepared (Table I).
The questionnaire covered: personal information
such as initials, sex, age, date and place of birth, with
consideration of iodine level (iodine deficiency region:
slight/moderate/serious); parents’ place of birth (region
of Poland along with iodine level, including the parts
of Ukraine, Belarus and Lithuania which used to be-
long to Poland before World War II); positive family
history of thyroid cancer of the first and second degree;
in women the number of deliveries, contraception and
hormonal replacement therapy. Socio-economic factors
covered were: education level (in a four-point scale: ele-
mentary/vocational/secondary/higher) and place of resi-
dence (country, town). Anthropometrical parameters
covered were: height (cm), body mass (kg) and body mass
index (BMI kg/m2), medical history: date of cancer being
diagnosed, diagnostics and treatment methods.
The control group consisted of 589 healthy subjects
selected based on age and place of residence who con-
sented to take part in the study (Table II). Statistical
analysis was done using Statistica 7PL software. Logis-
tic analysis for change odds ratio was applied to anal-
yse the effect of risk factors on cancer at 95% CI. The
Table II. Characteristics of members of control group who
responded
Tabela II. Charakterystyka osób z grupy kontrolnej objętych
badaniami ankietowymi
Control group n=589
Age (years) Sex n (%) Average
age (years) ± SD
0–18 Girls 7 (58.33) 16.71 ± 1.38
Boys 5 (41.67) 13.80 ± 2.17
 > 18 Women 507 (87.87) 50.92 ± 13.01
Men 70 (12.13) 46.33 ± 13.71
 0–85+ Women 514 (87.27) 50.46 ± 13.52
Men 75 (12.73) 44.16 ± 15.56
Total 589 (100.00) 49.66 ± 13.46
Table I. Characteristics of patients with thyroid cancer who
responded
Tabela I. Charakterystyka badanej grupy chorych na raka
tarczycy objętych badaniami ankietowymi
Characteristics of patients n (%)
with thyroid cancer
Number of patients with thyroid 462 (100.00)
cancer registered
Number of patients with thyroid 77 (16.66)
cancer who died
Patients responded 
Personally 139 (30.08)
By mail 151 (32.68)
By phone 4 (0.86)
From members of family 3 (0.64)
Total 297 (64.28)
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hypotheses about a relation (or lack of relation) between
variables in the nominal or ordinal scale was verified
using Pearson test and Highest Credibility test. Poisson
distribution was used for analysis of disease incidence.
Results
Between 1994 and 2003, 297 patients completed the
‘Questionnaire on thyroid carcinoma’, as did 589
healthy subjects from the control group. Age group dis-
tribution was similar for patients with carcinoma and
healthy subjects. The largest group was that of patients
aged 50–54 (Fig. 1). Women were predominant (Fig. 2).
Figure 3 illustrates that the number of children born to
women with thyroid carcinoma and those from the con-
trol group did not differ significantly. Figure 4 shows
that 10% of the women with carcinoma and 11% of the
healthy ones used contraception, with no statistical dif-
ferences between groups. Patients with thyroid carci-
noma and those from the control group were most fre-
quently born in Olsztyn province, which indicates that
they originated from an area of relative iodine deficiency
(Table III). The place of birth of all study subjects is
graphically presented in Figure 5. 9.72% of patients with
thyroid carcinoma and 7.41% of control patients suf-
fered from thyroid disease in childhood: the groups did
not differ statistically (Fig. 6). No statistically significant
differences were found in the family history of thyroid
diseases (32.41% of the sufferers from cancer v. 30.22%
of the control group) (Fig. 7).
Mothers of patients with thyroid carcinoma and of
healthy subjects most frequently came from regions of
similar iodine levels (Table IV). The data is graphically
presented in Figure 8. The fathers in both groups also
most frequently came from Warsaw province (17.08%
and 18.84%, respectively). The origin of the remaining
ones was the same as of the mothers (what is now
Lithuania and Olsztyn province); in general, most men
were born in areas of moderate iodine deficiency (Ta-
ble V, Fig. 9).
Within the group of patients with carcinoma, 108
(36%) had elementary education, 41 (14%) had voca-
Figure 1. Age characteristics of study group who responded
Rycina 1. Charakterystyka badanych grup objętych badaniami ankietowymi z uwzględnieniem wieku
Figure 2. Sex characteristics of study group who responded
Rycina 2. Charakterystyka badanych grup objętych badaniami
ankietowymi z uwzględnieniem płci
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tional, 113 (38%) had secondary and 38 (13%) had gone
throughhigher education. The same was true of the
control group (Fig. 10). No significant differences were
found concerning the place of residence (75.54% and
77.25%, respectively) (Fig. 11). Based on analysis with
logistic regression method it was shown that the risk of
thyroid carcinoma increased 0.98 times (CI 0.97–0.99)
in each person younger by a year. Individuals with low-
er body mass had 0.98 times (CI 0.96–0.99) greater risk of
developing the disease by each kilogram (Table VI). No
significant relationships were found for the remaining
risk factors such as family history of thyroid disease, ei-
Table III. Place of birth: study group vs. control group
Tabela III. Miejsce urodzenia badanej grupy chorych na raka
tarczycy i grupy kontrolnej
Place of birth Study Control
group n (%) group n (%)
Białostockie 9 (3.06) 19 (3.22)
Bielskie 1 (0.34) 2 (0.33)
Bydgoskie 5 (1.70)
Ciechanowskie 6 (2.04) 13 (2.20)
Elbląskie 1 (0.34)
Gdańskie 2 (0.68) 4 (0.67)
Katowickie
Kieleckie 2 (0.68) 2 (0.33)
Koszalińskie 1 (0.34)
Krakowskie 3 (1.02) 2 (0.33)
Lubelskie 11 (3.74) 12 (2.03)
Łomżyńskie 9 (3.06) 5 (0.85)
Łódzkie 1 (0.34) 9 (1.52)
Nowosądeckie 1 (0.16)
Olsztyńskie 140 (47.61) 350 (59.42)
Opolskie 2 (0.68)
Ostrołęckie 5 (1.70) 22 (3.73)
Piotrkowskie 2 (0.33)
Płockie 3 (0.51)
Poznańskie 3 (1.02)
Przemyskie 1 (0.16)
Rzeszowskie 11 (3.74) 10 (1.69)
Suwalskie 1 (0.34) 6 (1.01)
Tarnowskie 1 (0.16)
Toruńskie 3 (1.02) 2 (0.33)
Warszawskie 33 (11.22) 61 (10.35)
Wrocławskie 1 (0.34)
Zamojskie
Belarus 5 (1.70) 12 (2.03)
France
Lithuania 33 (11.22) 44 (7.47)
Latvia
Russia 1 (0.34)
Siberia
Ukraine 5 (1.70) 6 (1.01)
USA
Unknown
Total 294 (100) 589 (100)
Figure 3. Number of children: study group v. control group
Rycina 3. Liczba odbytych porodów w badanej grupie kobiet
chorych na raka tarczycy i grupie kontrolnej
Figure 4. Contraception: study group v. control group
Rycina 4. Częstość stosowania antykoncepcji w badanej grupie
kobiet chorych na raka tarczycy i grupie kontrolnej
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Place of birth beyond Poland (not marked on the map) Study group n (%) Control group n (%)
Belarus 5 (1.70) 12 (2.03)
France 0 (0.00) 0 (0.00)
Lithuania 33 (12.22) 44 (7.47)
Latvia 0 (0.00) 0 (0.00)
Russia 1 (0.34) 0 (0.00)
Siberia 0 (0.00) 0 (0.00)
Ukraine 5 (1.70) 6 (1.01)
USA 0 (0.00) 0 (0.00)
Total 64 (21.77)       62 (10.52)
Figure 5. Place of birth: study group v. control group
Rycina 5. Miejsce urodzenia badanej grupy chorych na raka tarczycy i grupy kontrolnej
ther among patients or their families, the number of chil-
dren they had, the age at delivery, or contraception used.
Discussion
Individual risk factors
Age of patients
No cases of thyroid carcinoma were registered in the
youngest groups aged 0–9; in older groups, i.e. 10–19,
there were 15 cases (7 girls and 8 boys). Our observa-
tions confirmed the results of other studies which have
shown that thyroid carcinoma occurs in children and
youths very rarely [5, 19, 20]. From the data analysis with
logistic regression method it followed that each individ-
ual younger by a year had a 0.98 times higher risk (95%
CI 0.97–0.99) of developing this kind of cancer.
The low incidence of cancer among children and
youths in the studied province can be accounted for by
a considerably lower dose of radiation in Poland than
experienced in Ukraine and Belarus on the one hand,
and by the effectively carried out iodine prophylactic
action during the post-Chernobyl period on the other
[21, 22]. Most probably for that reason, the cases of thy-
roid carcinoma were most frequently registered be-
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tween the ages of 30 and 50 and this age group made
a significant risk factor for thyroid cancer.
Sex of patients
The data from Olsztyn province showed that the high inci-
dence of thyroid carcinoma, with a significant rising trend
over the 10 years, concerned mainly women, and the wom-
en to men ratio was 5.8:1. The results of our study agree
with most data from Poland and elsewhere [20, 22, 24–28].
It is generally thought that the main reasons for
the elevated incidence of thyroid carcinoma in wom-
en are hormonal factors, mainly oestrogens, which
Figure 6. Subjects with thyroid diseases history:study group v.
control group
Rycina 6. Wywiady chorób tarczycy w badanej grupie chorych
na raka tarczycy i grupie kontrolnej
Figure 7. Subjects with thyroid diseases 1st degree family
history:study group v. control group
Rycina 7. Wywiady chorób tarczycy w rodzinie w badanej grupie
chorych na raka tarczycy i grupie kontrolnej
Table IV. Place of mother’s birth: study group v. control group
Tabela IV. Miejsce urodzenia matek badanej grupy chorych
na raka tarczycy i grupy kontrolnej
Place of mother’s birth Study Control
group N (%) group n (%)
Białostockie 1 (0.17)
Bielskie 2 (0.68) 2 (0.33)
Bydgoskie 6 (2.04)
Ciechanowskie 11 (3.74) 23 (3.90)
Częstochowskie 1 (0.17)
Elbląskie
Gdańskie 5 (1.70) 6 (1.01)
Katowickie 1 (0.34)
Kieleckie 5 (1.70) 7 (1.18)
Koszalińskie 1 (0.17)
Krakowskie 3 (1.02) 10 (1.69)
Lubelskie 20 (6.80) 29 (4.92)
Łomżyńskie
Łódzkie 14 (4.76) 27 (4.58)
Nowosądeckie 2 (0.33)
Olsztyńskie 40 (13.60) 105 (17.82)
Opolskie 1 (0.34)
Ostrołęckie 12 (4.08) 48 (8.14)
Piotrkowskie 1 (0.34) 4 (0.67)
Płockie 4 (1.36) 4 (0.67)
Poznańskie 5 (1.70) 3 (0.51)
Przemyskie 5 (0.85)
Rzeszowskie 17 (5.78) 23 (3.90)
Suwalskie 4 (1.36) 14 (2.37)
Tarnowskie 3 (0.51)
Toruńskie 1 (0.34) 5 (0.85)
Warszawskie 50 (17.00) 117 (19.86)
Wrocławskie 1 (0.17)
Belarus 27 (9.18) 56 (9.51)
France
Lithuania 47 (15.98) 72 (12.22)
Latvia 1 (0.17)
Russia 2 (0.68) 1 (0.17)
Siberia
Ukraine 12 (4.08) 16 (2.71)
USA 1 (0.17)
Unknown 4 (1.36) 3 (0.51)
Total 294 (100) 589 (100)
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Place of birth beyond Poland  (not marked on the map) Study group n (%) Control group n (%)
Belarus 27 (9.18) 56 (9.51)
France 0 (0.00) 0 (0.00)
Lithuania 47 (15.98) 72 (12.22)
Latvia 0 (0.00) 1 (0.17)
Russia 2 (0.68) 1 (0.17)
Siberia 0 (0.00) 0 (0.00)
Ukraine 12 (1.36) 16 (2.71)
USA 0 (0.00) 1 (0.17)
Total 88 (29.93) 147 (24.95)
Figure 8. Place of mother’s birth: study group v. control group
Rycina 8. Miejsce urodzenia matek badanej grupy chorych na raka tarczycy i grupy kontrolnej
probably affect  carcinogenesis. Oestrogens, endoge-
nous and exogenous, (hormonal contraception and
HRT), may stimulate TSH production and, in conse-
quence, cause thyroid hyperplasia and increase the risk
of cancer [29, 30].
Numerous studies on the effect of the number of
past pregnancies, or age at first conception, or number
of consecutive pregnancies, on the development of thy-
roid carcinoma provide some contradictory results [31–
–38]. A few studies have reported that women who had
experienced several pregnancies were exposed to the
development of thyroid carcinoma much more often,
especially as a result of radiation [39, 40]. Also in Po-
land, based on the observation of the population of
Krakow, it has been found that women with more
than one child have a greater risk of thyroid carcino-
ma [41]. We found that neither the number of past
pregnancies, nor the mother’s age at first giving birth,
nor consecutive children, was related to an increased
risk of cancer.
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Table V. Place of father’s birth: study group v. control group
Tabela V. Miejsce urodzenia ojców badanej grupy chorych
na raka tarczycy i grupy kontrolnej
Place of father’s birth Study Control
group n (%)  group n (%)
Białostockie 11 (3.74) 48 (8.14)
Bielskie 1 (0.34) 2 (0.33)
Bydgoskie 5 (1.70)
Ciechanowskie 12 (4.08) 18 (3.05)
Częstochowskie 1 (0.16)
Elbląskie
Gdańskie 6 (2.04) 8 (1.35)
Katowickie 1 (0.34)
Kieleckie 3 (1.02) 9 (1.52)
Koszalińskie
Krakowskie 3 (1.02) 10 (1.69)
Lubelskie 21 (7.14) 31 (5.26)
Łomżyńskie 11 (3.72) 22 (3.73)
Łódzkie 5 (1.70) 10 (1.69)
Nowosądeckie 3 (0.51)
Olsztyńskie 43 (14.62) 100 (16.97)
Opolskie
Ostrołęckie 11 (3.74) 44 (7.47)
Piotrkowskie 1 (0.34) 5 (0.85)
Płockie 3 (1.02) 3 (0.51)
Poznańskie 3 (1.02) 10 (1.69)
Przemyskie 6 (1.01)
Rzeszowskie 21 (7.14) 29 (4.92)
Suwalskie 2 (0.68) 12 (2.03)
Tarnowskie 1 (0.16)
Toruńskie 1 (0.34) 5 (0.85)
Warszawskie 52 (17.68) 111 (18.84)
Wrocławskie 1 (0.34)
Belarus 10 (3.40) 8 (1.35)
France 1 (0.16)
Lithuania 45 (15.31) 68 (11.54)
Latvia 1 (0.16)
Russia 1 (0.34) 1 (0.16)
Siberia
Ukraine 13 (4.42) 18 (3.05)
USA
Unknown 8 (2.72) 5 (0.85)
Total 294 (100) 589 (100)
The study did not reveal a significant relationship
between oestrogens used in contraception or HRT and
the incidence of thyroid carcinoma; however, the con-
clusions from the study may not be unequivocal, as the
patients from Olsztyn province, of either the carcino-
ma or the control group, rarely used hormonal contra-
ception or replacement therapy.
In urban areas in the south of Poland, it has been
observed that thyroid carcinoma occurs more often in
women using contraception [41]. Also, La Veccia in his
meta-analysis of 13 studies, observed a slight increase
in thyroid carcinoma incidence in women who had pre-
viously used hormonal contraception, although he did
not find a relationship between the age of its first use or
using it before giving birth to the first child [31, 42, 43].
Like us, other researchers have not confirmed a rela-
tion between contraception used and an increase in
thyroid carcinoma [34,38,44]. In turn, Sakoda observed
a decreased thyroid carcinoma risk in women using
contraception [34, 45].
Body mass of patients
The effect of anthropometric indicators (height, body
mass) on thyroid carcinoma was assessed in a meta-
analysis of 12 studies made by Dal Maso et al.; a moder-
ate effect of body height and mass on thyroid carcino-
ma was observed [46]. In Poland, in the Krakow popu-
lation, thyroid carcinoma occurred significantly more
often in obese men; but no such observations were made
for women [41]. Our study showed, using the logistic
regression model, that a higher risk of thyroid cancer
was run by individuals with lower body mass. The risk
decreased 0.98 fold (95% CI 0.96–0.99) with each extra
kilogram of body mass.
Family history of thyroid diseases
Numerous papers have stressed that there is a relation-
ship between previous nodular goitre and later occur-
rence of thyroid carcinoma [36, 38, 47–52]. The debate
as to whether the increase in thyroid cancer in patients
with nodular goitre is only the natural consequence of
thyroid carcinoma growth, or if the increase is related
to advanced techniques and more precise diagnostics,
continues. Some authors have suggested that the ob-
served growth in thyroid carcinoma incidence is the
effect of advances in medicine and better access to spe-
cialists [53–55]. In the presented material, 9% of patients
with cancer had a positive family history of thyroid dis-
ease in childhood, and 80% had nodular goitre, Hash-
imoto’s thyroiditis or Graves’ (also known as Basedow’s)
disease prior to diagnosis of thyroid cancer. Following
recognition of nodular goitre, more than 80% of patients
were referred for surgery within two years. In patients
with thyroid carcinoma with a large goitre, one of the
actual reasons for late diagnosis was the difficulty of
accessing specialists. Hence, the suggestion that the
development of specialist medical care could cause
‘overdiagnosing’ of carcinoma seems groundless. In
such cases, early surgical treatment of thyroid carcino-
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Place of birth beyond Poland  (not marked on the map) Study group n (%) Control group n (%)
Belarus 10 (3.40) 8 (1.35)
France 0 (0.00) 1 (0.16)
Lithuania 45 (15.31) 68 (11.54)
Latvia 0 (0.00) 1 (0.16)
Russia 1 (0.34) 0 (0.00)
Siberia 0 (0.00) 1 (0.16)
Ukraine 13 (4.42) 18 (3.05)
USA 0 (0.00) 0 (0.00)
Total 69 (23.47) 97 (16.46)
Figure 9. Place of father’s birth: study group v. control group
Rycina 9. Miejsce urodzenia ojców badanej grupy chorych na raka tarczycy i grupy kontrolnej
ma, when the neoplasm lesion was small and there were
no metastases, permits effective therapy.
In our study, as many as 30% of the patients had
a positive thyroid family history. There is extensive data
indicating that positive family history of nodular goitre
was one of the factors which might affect the develop-
ment of thyroid carcinoma [47, 56–60]. On the other
hand, it should be pointed out that individuals from
families with a positive history of nodular goitre were
more interested in diagnosing this condition; they were
more willing to agree to strumectomy, which is able
to diagnose thyroid carcinoma in stadium T1. Yet, our
study did not confirm univocally unequivocally that
positive family history in patients and in their families
was a significant risk factor for development of thyroid
carcinoma.
Family history of cancer
Several studies have pointed out the more frequent co-
occurrence of thyroid carcinoma with mammary gland
carcinoma in women [61]. One of the reasons for this
was risk factors common for both cancers, such as
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Figure 11. Place of residence: study group v. control group
Rycina 11. Miejsce zamieszkania badanej grupy chorych na raka
tarczycy i grupy kontrolnej
Table VI. Thyroid carcinoma risk factors in study group for
change odds ratio (OR)
Tabela VI. Czynniki ryzyka zachorowania na raka tarczycy
w badanej grupie chorych z określeniem ilorazu szans (OR)
dla zmiany jednostkowej
Risk factors OR (95% CI) p
Age onset of thyroid 0.98 (0.97–0.99) 0.03
cancer
Body mass 0.98 (0.96–0.99) 0.00
Consumption of cruciferous
vegetables 1.53 (1.19–1.96) 0.00
Cigarette smoking 0.54 (0.39–0.73) 0.00
Figure 10. Education: study group v. control group
Rycina 10. Poziom wykształcenia badanej grupy chorych na raka
tarczycy i grupy kontrolnej
family history of thyroid carcinoma, obesity and expo-
sure to ionising radiation [61]. In the material, only two
women with previously diagnosed mammary gland
carcinoma developed thyroid carcinoma, while in an-
other three the order was reversed. In one woman, fol-
lowing a diagnosis of thyroid cancer, kidney cancer was
found. One man had chronic lymphatic leukaemia,
another underwent radiotherapy of the chest due to
immature cell dumbbell ganglioneuroma at the age of
four (he developed thyroid carcinoma 17 years later).
In view of the presented results, it is difficult to draw
general conclusions on any relationships between thy-
roid cancer and cancer of other organs.
Birth place of patients
Researchers are not fully convinced as to whether be-
ing born in a region of iodine deficiency may affect the
development of thyroid carcinoma. Judging from
worldwide studies, living more than 20 years in an area
of iodine deficiency might have a slight effect on the
growth of thyroid cancer. The relationship is more
strongly evident for follicular cancer, in elderly patients.
Among women this relation is not clear [62]. In our
material, most of both the patients with carcinoma and
the control subjects were born in an area of moderate
iodine deficiency, i.e. Olsztyn and Warsaw provinces
or the present territory of Lithuania; only a few were
born in the area of endemic thyroid goitre (Krakow
province). Therefore, our observations do not allow us
to make firm conclusions. Yet, considering patients’ age
and bearing in mind the fact that table salt iodisation
was introduced in Poland in 1935, it can be stated with
confidence that most of the oldest patients would have
received iodine prophylaxis soon after they were born,
although it was suspended in 1939 for the period of
World War II and several years afterwards [63, 64]. This
fact may be related to the increase in thyroid cancer in-
cidence among the group of 60-year olds. Another sig-
nificant problem requiring future study is the estima-
tion of the effect of cessation of iodine prophylaxis in
Poland in the 1980s and 1990s on the growth of thyroid
carcinoma. In that period, the post-war generation of
Poles entered their maturity.
In 1986, there appeared one more risk factor: radia-
tion following the Chernobyl accident. The residents of
our province were acutely exposed. In this situation,
the examined population faced a combination of two
most serious risk factors for thyroid cancer. The conse-
quences lie still ahead of us.
Birth place of parents
While analysing the birthplaces of parents, we traced
back the migration of population to the area of Olsztyn
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province after the war. The place of birth of mothers
and fathers of patients with carcinoma and control
group subjects showed their similar origin from War-
saw and Olsztyn provinces and the present territory of
Lithuania, areas of moderate iodine deficiency. There
is no unequivocal evidence that moderate iodine defi-
ciency there had any effect on the increase in thyroid
carcinoma incidence.
Socio-economic factors
Patients’ education level
Our results did not reveal any effect of education level
on the occurrence of thyroid cancer. In the study group,
50% of patients had elementary education and 13% had
higher education. Similar results were obtained in the
control group and they reflect the general education
level of the Polish population [12]. So far, there is no
information available on the relationship between ed-
ucation level and risk of thyroid carcinoma. In New
Caledonia, 75.8% of patients with thyroid cancer had
low education level; in contrast, in Iribarren’s study,
higher education was a risk factor for thyroid cancer
[38, 65].
Patients’ place of residence
Studies conducted in Poland have shown that thyroid
cancer develops most often in residents of towns [20,
21]. Our results seem to confirm this observation. This
could be also due to the fact that urban dwellers have
better access to specialists and diagnostic procedures,
as well as better health education. On the other hand, it
may follow from greater environmental pollution of the
urban environment. There is no firm and clear evidence
worldwide on the effect of residence place on the de-
velopment of thyroid cancer. Romanian researchers
found a greater incidence of thyroid carcinoma among
the inhabitants of urban Cluj-Napoca area [66]; in Swe-
den, a greater carcinoma incidence was observed in
towns, while that of follicular carcinoma in women, and
of anaplastic carcinoma in both sexes, was greater in
rural areas [62].
Conclusions
The risk factors for the incidence of thyroid carcinoma
in the studied area were: female sex, age onset of thy-
roid cancer, low body mass of patients.
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